Colorectal Cancer
Conditions
Interventions
Gold Standard:The double-blinded clinical trial was conducted to simultaneously assessing the kit with colonoscopy and/or pathological examinations for the detection of colorectal cancer. The overall
kit 
of 
the 
and 
method)(Product 
iColocomf?)
Sponsors
Peking Union Medical College Hospital, Chinese Academy of Medical Sciences
Eligibility
Sex/Gender
All
Age
21 Years to 80 Years
Inclusion criteria
Inclusion criteria: Colorectal cancer enrollment requirements: 1. Adult population aged 18 years or older; 2. Patients who are clinically diagnosed as requiring colonoscopy and who are scheduled to undergo colonoscopy soon; 3. patients with high suspicion of colorectal cancer diagnosed by colonoscopy or pathological biopsy, and who have not undergone surgery and histopathological examination. For patients with interfering disease other than bowel cancer, the entry requirements are 1. aged 18 years or older in the adult population; 2. patients with other gastrointestinal cancers (including esophageal cancer, gastric cancer, liver cancer, pancreatic cancer, bile duct cancer, etc.) and other benign gastrointestinal diseases (including esophagitis, gastritis, enteritis, inflammatory bowel disease, appendicitis, peptic ulcer, colorectal polyps, colorectal adenoma, hemorrhoids, etc.) who are scheduled to undergo colonoscopy or already have colonoscopy results and are untreated.
Exclusion criteria
Exclusion criteria: Exclusion Criteria Any of the following conditions can be excluded if any of the following are met. (1) Unclear pathological results. (2) The sample has been contaminated, not preserved as required, or the sample volume is insufficient. (3) Incomplete medical history information. (4) Samples with insufficient total extracted DNA samples (5) Samples whose internal control Ct still does not meet the quality control requirements after sample retesting.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sensitivity;Specificity;Accuracy;Kappa; | — |
Countries
China
Contacts
Public ContactYaling Dou
Peking Union Medical College Hospital, Chinese Academy of Medical Sciences
Outcome results
None listed